Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,780 | 63,377 | 93,501 | 54,724 | 43,248 |
| Marketable Securities | 582,567 | 648,994 | 665,016 | 298,818 | 392,912 |
| Receivables | 38,044 | 32,822 | 36,360 | 29,440 | 25,694 |
| TOTAL | $721,315 | $769,084 | $819,189 | $402,801 | $482,425 |
| Non-Current Assets | |||||
| PPE Net | 5,202 | 5,973 | 6,814 | 7,464 | 10,411 |
| Other Non-Current Assets | 28,369 | 27,037 | 26,966 | 27,993 | 16,331 |
| TOTAL | $33,571 | $33,010 | $33,780 | $35,457 | $26,742 |
| Total Assets | $754,886 | $802,094 | $852,969 | $438,258 | $509,167 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 153,968 | 133,295 | 115,562 | 101,886 | 105,109 |
| TOTAL | $162,005 | $139,974 | $125,234 | $108,341 | $114,205 |
| Non-Current Liabilities | |||||
| Long Term Debt | 532,078 | 525,339 | 545,009 | 375,351 | 371,250 |
| Deferred Revenues | N/A | 1,216 | 1,622 | 2,717 | 1,621 |
| Other Non-Current Liabilities | 9,247 | 6,046 | 7,523 | 9,162 | 3,771 |
| TOTAL | $541,325 | $531,385 | $552,532 | $384,918 | $375,832 |
| Total Liabilities | $703,330 | $671,359 | $677,766 | $493,259 | $490,037 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,853 | 32,733 | 32,696 | 29,777 | 29,694 |
| Common Shares | 33 | 33 | 33 | 30 | 30 |
| Retained earnings | -2,123,466 | -2,025,308 | -1,940,475 | -1,869,055 | -1,778,785 |
| Other shareholders' equity | -1,144 | -1,070 | -836 | -1,169 | -2,259 |
| TOTAL | $51,556 | $130,735 | $175,203 | $-55,001 | $19,130 |
| Total Liabilities And Equity | $754,886 | $802,094 | $852,969 | $438,258 | $509,167 |